Jubilant Pharma Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
3,200
- Latest Deal Type
-
Debt Repay.
- Latest Deal Amount
-
$25M
Jubilant Pharma General Information
Description
Producer and supplier of pharmaceutical products worldwide. The company offers allergy therapy products, active pharmaceutical ingredients, and drugs intended to cure generic diseases, along with radiopharmacy and contract manufacturing services.
Contact Information
Website
www.jubilantpharma.comCorporate Office
- 790 Township Line Road
- Suite 325
- Yardley, PA 19067
- United States
Corporate Office
- 790 Township Line Road
- Suite 325
- Yardley, PA 19067
- United States
Jubilant Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Debt Repayment | 01-Oct-2023 | $25M | Completed | Generating Revenue | ||
| 2. Debt Refinancing | 13-Jul-2022 | Completed | Generating Revenue | |||
| 1. Debt - General | Completed | Generating Revenue |
Jubilant Pharma Comparisons
Industry
Financing
Details
Jubilant Pharma Competitors (15)
One of Jubilant Pharma’s 15 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan |
Jubilant Pharma Patents
Jubilant Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230046186-A1 | Process for the preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof | Inactive | 29-Jul-2021 | ||
| US-20230000837-A1 | Parenteral dosage form of beta 3 adrenoreceptor agonists | Inactive | 29-Jun-2021 | ||
| US-11311518-B1 | Parenteral dosage form of β3 adrenoreceptor agonists | Inactive | 29-Jun-2021 | ||
| WO-2022155507-A1 | Transmucosal dosage forms of brexanolone | Inactive | 15-Jan-2021 | ||
| WO-2022153334-A1 | Transmucosal dosage forms of foscarnet | Inactive | 15-Jan-2021 | A61P31/18 |
Jubilant Pharma Signals
Jubilant Pharma FAQs
-
When was Jubilant Pharma founded?
Jubilant Pharma was founded in 2014.
-
Where is Jubilant Pharma headquartered?
Jubilant Pharma is headquartered in Yardley, PA.
-
What is the size of Jubilant Pharma?
Jubilant Pharma has 3,200 total employees.
-
What industry is Jubilant Pharma in?
Jubilant Pharma’s primary industry is Drug Delivery.
-
Is Jubilant Pharma a private or public company?
Jubilant Pharma is a Private company.
-
What is Jubilant Pharma’s current revenue?
The current revenue for Jubilant Pharma is .
-
How much funding has Jubilant Pharma raised over time?
Jubilant Pharma has raised $400M.
-
Who are Jubilant Pharma’s competitors?
Pfizer (Vienna), Evonile Pharma, Novartis, Teva Pharmaceutical Industries, and Pfizer Pakistan are some of the 15 competitors of Jubilant Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process